Literature DB >> 9346330

Effects of neuropeptide FF on intestinal motility and temperature changes induced by endotoxin and platelet-activating factor.

M Million1, J Fioramonti, J M Zajac, L Buéno.   

Abstract

Several effects of bacterial endotoxins involve an opioid pathway and neuropeptide FF is an endogenous peptide known to modulate opioid activity, mainly in the central nervous system. The aim of this study was to investigate in rats the role of central neuropeptide FF receptors in intestinal motor disturbances and body temperature changes induced by endotoxins and platelet-activating factor (PAF), a major endotoxin mediator. Rats were fitted with intestinal electrodes, an intraperitoneal thermistor probe and an intracerebroventricular (i.c.v.) cannula for long-term use. E. coli endotoxin (100 microg/kg, i.v.) disrupted the cyclic pattern of intestinal migrating myoelectric complexes and induced a biphasic increase in body temperature while PAF (25 microg/kg, i.p.) disrupted the migrating myoelectric complexes and induced hypothermia for about 2 h. The neuropeptide FF analog, (1 DME)Y8Fa (D-Tyr-D-Leu[N-Me]-Phe-Gln-Pro-Gln-Arg-Phe-NH2) administered i.c.v. 40 and 100 microg/kg reduced the duration of migrating myoelectric complex disruption induced by endotoxin and PAF and abolished the PAF-induced hypothermia. Only at the dose of 100 microg/kg did (1 DME)Y8Fa change the biphasic endotoxin-induced hyperthermia into a monophasic increase. Naloxone (1 mg/kg, s.c.) reduced only the duration of migrating myoelectric complex disruption induced by endotoxin. These results indicate that central neuropeptide FF modulates the intestinal motor disturbances and changes in body temperature induced by endotoxin and PAF. Its action against endotoxin may involve an anti-opioid pathway whereas its action against PAF does not.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9346330     DOI: 10.1016/s0014-2999(97)01142-4

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  5 in total

1.  IgG subclasses determine pathways of anaphylaxis in mice.

Authors:  Héloïse Beutier; Caitlin M Gillis; Bruno Iannascoli; Ophélie Godon; Patrick England; Riccardo Sibilano; Laurent L Reber; Stephen J Galli; Mark S Cragg; Nico Van Rooijen; David A Mancardi; Pierre Bruhns; Friederike Jönsson
Journal:  J Allergy Clin Immunol       Date:  2016-04-26       Impact factor: 10.793

2.  Pathways of immediate hypothermia and leukocyte infiltration in an adjuvant-free mouse model of anaphylaxis.

Authors:  Bianca Balbino; Riccardo Sibilano; Philipp Starkl; Thomas Marichal; Nicolas Gaudenzio; Hajime Karasuyama; Pierre Bruhns; Mindy Tsai; Laurent L Reber; Stephen J Galli
Journal:  J Allergy Clin Immunol       Date:  2016-07-17       Impact factor: 10.793

3.  Mouse and human neutrophils induce anaphylaxis.

Authors:  Friederike Jönsson; David A Mancardi; Yoshihiro Kita; Hajime Karasuyama; Bruno Iannascoli; Nico Van Rooijen; Takao Shimizu; Marc Daëron; Pierre Bruhns
Journal:  J Clin Invest       Date:  2011-03-23       Impact factor: 14.808

4.  Platelet-activating factor: a previously unrecognized mediator of fever.

Authors:  Andrei I Ivanov; Shreya Patel; Vladimir A Kulchitsky; Andrej A Romanovsky
Journal:  J Physiol       Date:  2003-10-17       Impact factor: 5.182

5.  Quinidine, but not eicosanoid antagonists or dexamethasone, protect the gut from platelet activating factor-induced vasoconstriction, edema and paralysis.

Authors:  Ingmar Lautenschläger; Inéz Frerichs; Heike Dombrowsky; Jürgen Sarau; Torsten Goldmann; Karina Zitta; Martin Albrecht; Norbert Weiler; Stefan Uhlig
Journal:  PLoS One       Date:  2015-03-20       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.